Qiagen Nv earnings were $402.2M for the trailing 12 months ending Mar 31, 2026, with 334.9% growth year over year. The latest QGEN earnings report on Mar 31, 2026 announced Q1 2026 earnings of $68.0M, down 36.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, QGEN reported annual earnings of $424.9M, with 408.3% growth. The next QGEN earnings date is Aug 4, 2026.
QGEN past earnings growth
How has QGEN's earnings growth performed historically?
On QGEN's earnings call on Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q1 2026 earnings per share (EPS) of $0.33, up 21.43% year over year. Total QGEN earnings for the quarter were $68.04 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was $0.42.
The next QGEN earnings date is Invalid Date. Add QGEN to your watchlist to be reminded of Qiagen Nv's next earnings date.
Is Qiagen Nv profitable or losing money?
As of the last Qiagen Nv earnings report, Qiagen Nv is currently profitable. Qiagen Nv's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $402.17 million, a 329.31% increase year over year.
What was QGEN's earnings growth in the past year?
As of Qiagen Nv's earnings date in Invalid Date, Qiagen Nv's earnings has grown 334.88% year over year. This is 324.25 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.64%. QGEN earnings in the past year totalled $402.17 million.
What are Qiagen Nv's earnings expectations?
The current EPS estimate for Qiagen Nv's earnings report in Invalid Date is $0.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.